INOGENIX
Latest round
- Seed
Last raised
- Oct 2021
Total raised
- Undisclosed
Investors
- 1
About INOGENIX
Based in South Korea, INOGENIX specializes in molecular diagnostics, delivering innovative medical devices aimed at addressing critical clinical needs. The company focuses on enhancing patient outcomes through precise diagnostic solutions. Founded in 2019 and headquartered in Chuncheon-si, South Korea, INOGENIX operates in the field of molecular diagnostics. INOGENIX Inc. specializes in molecular diagnostics, delivering a range of innovative medical devices designed to address unmet clinical needs. Their core product offerings include the Atopy Prediction Service (AGA), Colorectal Cancer Test, INO MTB-Alive Detection, and COVID-19 testing solutions. These products leverage artificial intelligence to provide personalized medical services, aiming to enhance patient outcomes through precise diagnostics. The company primarily serves healthcare institutions, laboratories, and clinical practitioners, focusing on regions with high demand for advanced diagnostic tools, including North America and parts of Asia. By providing these solutions, INOGENIX aims to improve the quality of healthcare and patient well-being. INOGENIX operates through a business model that involves direct transactions with healthcare providers and laboratories, facilitating the delivery of their diagnostic products and services. The company’s revenue streams are derived from the sale of individual testing kits and subscription services for ongoing access to their diagnostic platforms. Healthcare institutions may engage in contractual agreements, wherein they purchase testing kits for various applications, such as cancer detection or infectious disease diagnostics. This structure suggests a focus on B2B relationships, catering to hospitals and specialty clinics that require advanced molecular testing.
Who invested in INOGENIX
1 investor across 1 round
See all investors in INOGENIX
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 25, 2021
Amount
Undisclosed
Investors
Questions about INOGENIX
Who invested in INOGENIX?
INOGENIX has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has INOGENIX raised?
INOGENIX has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did INOGENIX last raise money?
INOGENIX's most recent round on record is a Seed, in Oct 2021.
What does INOGENIX do?
Based in South Korea, INOGENIX specializes in molecular diagnostics, delivering innovative medical devices aimed at addressing critical clinical needs.
Where is INOGENIX headquartered?
INOGENIX is headquartered in Chuncheon-si, South Korea.
Which VCs invest in companies like INOGENIX?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back medical devices & equipment companies at INOGENIX's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like INOGENIX? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.